MYELODYSPLASTIC SYNDROME (MDS)
Clinical trials for MYELODYSPLASTIC SYNDROME (MDS) explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROME (MDS) trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROME (MDS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to stop blood cancer relapse after transplant
Disease control OngoingThis study is for people with high-risk blood cancers (AML, MDS, CMML) who are getting a donor stem cell transplant. Researchers want to see if adding the drug venetoclax to standard transplant preparation and to post-transplant maintenance therapy is safe and can help prevent th…
Matched conditions: MYELODYSPLASTIC SYNDROME (MDS)
Phase: PHASE1 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control
Last updated May 26, 2026 03:20 UTC
-
Promising drug combo targets High-Risk bone marrow cancer
Disease control OngoingThis study tests whether adding venetoclax to standard azacitidine helps people with a serious bone marrow disease called higher-risk MDS live longer. About 500 newly diagnosed adults will receive either the drug combo or azacitidine alone. The goal is to control the disease and …
Matched conditions: MYELODYSPLASTIC SYNDROME (MDS)
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
Scientists seek blood cancer samples to unlock new treatments
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects blood and bone marrow samples from 550 people with blood cancers like leukemia and lymphoma. Researchers will study the samples in the lab to learn more about how these cancers work and find new ways to treat them. Participants give samples during their regula…
Matched conditions: MYELODYSPLASTIC SYNDROME (MDS)
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 26, 2026 03:13 UTC